Skip to content

Kodiak Sciences Inc KOD Interest Income

Interest Income at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$3.72M+7.8%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$6.05M+58.1%
Vera Therapeutics logo
Vera TherapeuticsVERA
$6.36M-8.0%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$6M-14.3%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$2.28M-10.3%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$5.35M-31.5%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's interest income?
Kodiak Sciences Inc (KOD) reported interest income of $1.64M in Q1 2026.
How has Kodiak Sciences Inc's interest income changed year-over-year?
Kodiak Sciences Inc's interest income increased by 2.4% year-over-year, from $1.6M to $1.64M.
What is the long-term trend for Kodiak Sciences Inc's interest income?
Over 4 years (2021 to 2025), Kodiak Sciences Inc's interest income has grown at a 97.3% compound annual growth rate (CAGR), from $298K to $4.52M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.